2 recruiting, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 1 | 1 | Unknown 1 |
Follow GST-HG131: new trials by email Literature Review of GST-HG131 trials Research Report on GST-HG131
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B GST-HG141, GST-HG131, GST-HG141 Placebo - Chronic Hepatitis B | Phase 2 | Recruiting | Fujian Akeylink Biotechnology Co., Ltd. | 80 | 2026-07-10 | 2026-07-17 |
| A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B GST-HG131, Placebo to match GST-HG131 - Chronic Hepatitis B | Phase 2 | Recruiting | Fujian Akeylink Biotechnology Co., Ltd. | 45 | 2023-12-26 | 2025-03-05 |
| Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets GST-HG131 tablets, Placebo - Hepatitis B | Phase 1 | Unknown | Fujian Cosunter Pharmaceutical Co. Ltd | 124 | 2020-08-18 | 2020-09-24 |
Hepatitis B, Chronic (2) · Hepatitis B (1)
Fujian Akeylink Biotechnology Co., Ltd. (2) · Fujian Cosunter Pharmaceutical Co. Ltd (1)
China (3)
Junqi Niu, PHD (1)